ArticleTherapeutic advances in gastroenterology2025

Switch acceptance and persistence of adalimumab biosimilars in IBD patients: a prospective observational study.

Gabrielle D'Abbundo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.